Halbrecht Jeffrey L MD is categorized under Sports Medicines in San Francisco, CA and active since 1991.
Halbrecht Jeffrey L MD was established in 1991, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Sports Medicines business, which does work in the B2C market, and is classified as a Sports Medicines, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Halbrecht at the company’s single location by writing to 2100 Webster St # 331, San Francisco, California CA 94115 or by phoning (415) 923-0944. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Halbrecht Jeffrey L MD |
| Contact Person: | Jeffrey Halbrecht |
| Address: | 2100 Webster St # 331, San Francisco, California 94115 |
| Phone Number: | (415) 923-0944 |
| Website Address: | iasm.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1991 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Sports Medicines |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Halbrecht Jeffrey L MD was started in 1991 to provide professional Sports Medicines under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Jeffrey Halbrecht for inquiries that concern Halbrecht Jeffrey L MD by calling the company number (415) 923-0944, as your correspondence is most welcome. Additionally, the physical location of the single location of Halbrecht Jeffrey L MD can be found at the coordinates 37.790083,-122.43232 as well as the street address 2100 Webster St # 331 in San Francisco, California 94115.
For its online presence, you may visit Halbrecht Jeffrey L MD’s website at iasm.com and engage with its social media outlets through on Twitter and on Facebook.